What happened: A trial involving 19 women found that the radiotracer maraciclatide can highlight endometriosis on scans, potentially reducing the need for surgical diagnosis. This could speed up diagnosis times significantly.
Why it matters:
- Current diagnosis often requires surgery, causing delays of up to a decade in England.
- Faster, less invasive diagnosis could improve treatment and quality of life for many women.
MNN Take: The trial indicates that maraciclatide-enhanced scans may offer a safer, quicker alternative to surgery for diagnosing endometriosis, though further research is needed to confirm these findings.
Sources: Guardian UK